$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Sen. John Boozman Buys iShares Core S&P 500 ETF (NYSEARCA:IVV) Shares
02:02am, Monday, 16'th Feb 2026
Senator John Boozman (R-Arkansas) recently bought shares of iShares Core S&P 500 ETF (NYSEARCA:IVV). In a filing disclosed on February 15th, the Senator disclosed that they had bought between $1,001 a
Assetmark Inc. Raises Stake in CVS Health Corporation $CVS
04:02am, Saturday, 14'th Feb 2026
Assetmark Inc. increased its holdings in shares of CVS Health Corporation (NYSE: CVS) by 12.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities
CVS Health Corporation $CVS Shares Acquired by Atria Investments Inc
03:27am, Saturday, 14'th Feb 2026
Atria Investments Inc lifted its stake in shares of CVS Health Corporation (NYSE: CVS) by 13.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Saggio Realty Announces Milestone Linked to Sale of Marco Island's CVS-Anchored Plaza
08:20pm, Friday, 13'th Feb 2026
Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Comm
Dodge & Cox's Strategic Moves: A Closer Look at Brookfield Corp's Impact
02:00pm, Friday, 13'th Feb 2026
Insightful Analysis of Dodge and Cox (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Dodge and Cox recently submitted their 13F filing for the fourth quarter
CVS Health Corporation $CVS Shares Sold by Caisse Des Depots ET Consignations
06:53am, Thursday, 12'th Feb 2026
Caisse Des Depots ET Consignations lessened its holdings in shares of CVS Health Corporation (NYSE: CVS) by 51.5% during the undefined quarter, according to the company in its most recent 13F filing w
Caprock Group LLC Buys New Shares in CVS Health Corporation $CVS
05:34am, Thursday, 12'th Feb 2026
Caprock Group LLC purchased a new stake in shares of CVS Health Corporation (NYSE: CVS) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchang
Analysts See Multiple Growth Levers For CVS Health In 2026
02:31pm, Wednesday, 11'th Feb 2026
CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.
Advisors Asset Management Inc. Has $13.55 Million Position in CVS Health Corporation $CVS
04:10am, Wednesday, 11'th Feb 2026
Advisors Asset Management Inc. decreased its stake in CVS Health Corporation (NYSE: CVS) by 5.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities an
Major stock indexes were mixed Tuesday, with the Dow Jones Industrial Average setting a fresh all-time high for a third consecutive session. Meanwhile, Treasury yields ticked lower after delayed U.S.
CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026
02:45pm, Tuesday, 10'th Feb 2026
CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna d
CVS Reiterates 2026 Profit Outlook, Shares Slide 3.7% Despite Q4 Beat
02:13pm, Tuesday, 10'th Feb 2026
CVS Health Corp (CVS) unsettled investors after management chose to reiterate its 2026 profit outlook, a decision that came despite a stronger-than-expected fou
CVS Health Corp (CVS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
02:02pm, Tuesday, 10'th Feb 2026
Adjusted Operating Income (Q4 2025): $2.6 billionAdjusted Earnings Per Share (Q4 2025): $1.09Full Year 2025 Adjusted EPS: $6.75Operating Cash Flow (Full Year 2
CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market
12:45pm, Tuesday, 10'th Feb 2026
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
11:04am, Tuesday, 10'th Feb 2026
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
Sign In
Buy CVS